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Introduction
The incidence of breast cancer in Hong Kong is increasing.1
As reported by the Cancer Registry, in 1999, the crude inci-
dence and crude death rates were 53.5 and 11.8 in 100,000,
respectively. Breast cancer is now the second most common
cause of cancer deaths among women in our city. If modifiable
risk factors were corrected, the situation would probably im-
prove and fewer women would suffer from the detrimental
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emotional impact brought by the disease. High body weight
(measured in terms of body mass index, BMI) has been recog-
nized as an important risk factor for breast cancer among
postmenopausal women in many previous epidemiological
studies in Western countries.2–19 These investigations report a
positive relationship between breast cancer risk and high body
weight in postmenopausal women, while premenopausal
women were protected by higher BMI. The increased risk in
overweight postmenopausal women is chiefly due to higher
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levels of free oestrogen produced by excess aromatase activity
in peripheral adipose tissue.2 Conversely, the protective mecha-
nism among premenopausal women is not well understood.2
In other studies, weight at certain life points was reported to
be more important than just the current weight.4,6–8,13,20 In-
stead of using weight alone, we used a height-adjusted weight
index, the BMI, to observe the potential association with
breast cancer. In addition to BMI at the time of diagnosis, we
also took into account the BMI 5 years before the diagnosis of
breast cancer.
Although the association between high BMI and breast
cancer risk is well established, the vast majority of studies
were conducted in Western countries. Only a very few have
been carried out among Asian women,3,6,13,18 in particular,
Chinese.13 The aim of our study was to further elucidate this
correlation in Chinese women, and our main focus was on
BMI and its relationship to breast cancer risk.
Materials and methods
We performed a case control study to determine the relation-
ship between BMI and breast cancer risk among Chinese
women in Hong Kong. All subjects were selected from the
Breast Clinic at Queen Mary Hospital in June 2002. Eligible
cases included all females aged 24–85 years who had been
diagnosed with primary breast cancer by triple assessment
between 1995 and 2002. Triple assessment included clinical
examination by specialist surgeons, radiological assessment
and histological confirmation by senior pathologists. During
the study period, 247 eligible cases were identified from medi-
cal records and 198 (80%) participated in our study. The major
reasons for non-participation included refusal (10%), default
(5%) and being too ill to answer questions (5%). We excluded
subjects who had documented malignancy in other sites. Only
Chinese women were recruited. All patients had undergone
either mastectomy or breast-conserving surgery and adjuvant
chemotherapy, hormonal therapy or radiotherapy, as indicated.
Controls (n = 353) had a diagnosis of benign breast diseases
between 1995 and 2002 and primary breast cancer had been
excluded by triple assessment. They were aged 18–85 years.
The response rate was again 80%, with similar reasons for
non-participation: refusal (8.5%), default (6%) and being too
ill to answer questions (5.5%). Again, only Chinese women
were recruited.
A structured questionnaire was used to elicit detailed
information. Subjects were asked to complete the question-
naire under the guidance of medical students or medical staff.
Questions asked about body weight and height at present,
at the time of diagnosis, and at 5 years before the diagnosis,
and about other risk factors for breast cancer, including family
history of breast cancer, menopausal status, exercise habit,
smoking and drinking habit, pregnancy history and oral con-
traceptives use. Demographic data were also collected. Present
weight and height were objectively measured in both case and
control groups using standardized equipment.
Quartile distributions were used to categorize BMI to
facilitate comparisons: BMI below 23, 23–27, 27–31 and above
31. Odds ratios (ORs) were used to measure the association
between breast cancer risk and BMI. Logistic regression mod-
els gave the maximum likelihood estimates of OR with 95%
confidence interval (CI). According to Campbell and Monga,21
the worldwide mean age at menopause is 51 and, therefore, we
defined 51 at the time of diagnosis as the cut-off point for the
menopause, giving pre- and postmenopausal groups. Com-
parisons were drawn within each group concerning ORs for
BMI at the time of diagnosis, BMI 5 years before diagnosis, and
BMI at present. Tests for trends were performed by entering
categorical variables as continuous parameters in the model.
We performed data analysis using SPSS version 10.0 (SPSS Inc,
Chicago, IL, USA), and all tests of statistical significance were
two-sided.
Results
Table 1 compares demographic and traditional breast cancer
risk factors in cases and controls. Cases were slightly older
than controls (mean, 47.3 vs 43.6 years). The following analy-
sis was adjusted for age but not for other factors, because there
were no significant differences in education level, monthly
family income, number of pregnancies, family history of breast
cancer (especially first-degree relatives), alcohol consumption
and smoking.
Among postmenopausal women, the BMI at diagnosis was
positively associated with the risk of breast cancer (p < 0.001
for trend). The ORs for breast cancer increased with increasing
BMI (> 23, 1.73; > 27, 2.06; > 31, 3.82 after adjusting for non-
anthropometric risk factors) (Table 2), demonstrating a dose-
response relationship (Figure). BMI at diagnosis, however,
was not related to the risk of breast cancer among premeno-
pausal women (> 23, 1.5; > 27, 1.32 after adjusting for non-
anthropometric risk factors) (Table 2).
Present BMI was poorly associated with breast cancer
among both pre- and postmenopausal women (Table 3), as
was BMI 5 years before diagnosis (Table 4).
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Table 2. Association between body mass index (BMI) at diagnosis and breast cancer risk
BMI
Postmenopausal* Premenopausal†
Cases, n (%) Controls, n (%) Odds ratio (95% CI) Cases, n (%) Controls, n (%) Odds ratio (95% CI)
< 19 10 (8.3) 18 (13.7) 14 (19.7) 48 (22.6)
19–23 038 (31.4) 51 (38.9) 1.78 (0.79–4.04); p = 0.17 35 (49.3) 115 (54.2)0 1.19 (0.61–2.32); p = 0.61.
23–27 042 (34.7) 42 (32.1) 1.73 (1.04–2.86); p = 0.03 14 (19.7) 41 (19.3) 1.49 (0.82– 2.71); p = 0.19
27–31 020 (16.5) 15 (11.5) 2.06 (1.08–3.93); p = 0.03 5 (7.0) 8 (3.8) 1.32 (0.39–4.43); p = 0.63,
> 31 10 (8.3) 3 (2.3) 03.82 (1.03–14.27); p = 0.05 0 (4.2) 0((((((
Missing 01 (0.8) 2 (1.5) 3 (4.2)
*Trend: p < 0.001; †trend: p = 0.39. Cases and controls in each group were adjusted for age. CI = confidence interval.
Table 1. Demographics and selected breast cancer risk factors in cases and controls
Cases (n = 198) Controls (n = 358) p
Mean age, yr 55.4 44.5 < 0.001
Mean number of pregnancies 1.98 1.75 0.22
Family history of breast cancer before age 40 yr 15.7% 14.6% 0.88
Monthly income, US$ 2,230 2,647 0.07
Ever smoking 5.6% 6.6% 0.89
Regular alcohol user (drink every day) 5.1% 3.0% 0.05
Previous oral contraceptive pill use 32.3% 21.5% 0.36
Tertiary education 15.2% 19.2% 0.17
Figure. Age-adjusted odds ratio of body mass index (BMI) at the
time of diagnosis in postmenopausal women at different cut-off
BMIs. *p = 0.165; †p = 0.029; ‡p = 0.046.
Discussion
This population-based case control study found that the risk
of developing breast cancer increased with BMI at the time of
diagnosis in postmenopausal women (p < 0.001 for trend).
BMI at diagnosis, however, was not related to the risk of breast
cancer among premenopausal women. Furthermore, present
BMI and BMI 5 years before diagnosis were poorly associated
with breast cancer risk among both pre- and postmenopausal
women.
The poor association between present BMI and breast
cancer may be due to multiple factors, including the effect of
chemotherapy, radiotherapy and surgery on appetite and
changes in lifestyle after diagnosis. Appetite changes from
psychological effects on discovery of the disease may also
contribute. We could not assess the effect of different factors
on BMI for cases and controls, but the association between
BMI at diagnosis for pre- and postmenopausal women had
already fulfilled our requirement.
Our results are consistent with many previous studies,
which state that there is a positive correlation between BMI
and risk of breast cancer in postmenopausal women. They are
similar to results from a recent case control study in Chinese
women13 as well as previous studies in Western populations.
A large-scale meta-analysis involving 300,000 subjects in
1995 also gave similar results to ours among postmeno-
pausal women. Table 5 summarizes the risks of breast cancer
with a BMI cut-off of 27 in different studies.13,16,22
Our results among premenopausal women were also con-
sistent with some earlier studies.4,5,9,21,22 However, other stud-
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ies found that a greater BMI is protective in premenopausal
women. The risks of breast cancer with a BMI cut-off of 27 in
different studies are shown in Table 6.13,16,22
Some researchers proposed that the incidence of breast
cancer might be related to the number of years of obesity
instead of only pre- or postmenopausal status. One study
found that the risk of breast cancer in postmenopausal women
increased with maximal lifetime BMI.23 However, in premeno-
pausal women, the result was exactly opposite. Therefore, it
seems that the duration of obesity does not correlate well with
the risk of breast cancer in all women but in a subgroup of
postmenopausal women. The authors did not explain their
results, but they might indicate that there are two types of
breast cancer with two separate pathogeneses.
Table 4. Association between body mass index (BMI) 5 years before diagnosis and breast cancer risk
BMI
Postmenopausal* Premenopausal†
Cases, n (%) Controls, n (%) Odds ratio (95% CI) Cases, n (%) Controls, n (%) Odds ratio (95% CI)
< 19 5 (7.1) 7 (9.5) 23 (19.2) 59 (21.8)
19–23 21 (30.0) 27 (36.5) 0.97 (0.34–2.74), p = 0.954 53 (44.2) 140 (51.7) 1.17 (0.69–2.01), p = 0.560
23–27 24 (34.3) 26 (35.1) 1.33 (0.69–2.55), p = 0.395 31 (25.8) 58 (21.4) 1.12 (1.01–2.53), p = 0.045
27–31 12 (17.1) 10 (13.5) 1.64 (0.76–3.57), p = 0.209 9 (7.5) 14 (5.2) 2.23 (1.01–4.09), p = 0.046
> 31 8 (11.4) 4 (5.4) 2.18 (0.63–7.60), p = 0.219 4 (3.3) 0 N/A
Missing 5 (7.1) 7 (9.5) 23 (19.2) 59 (21.8)
*Trend: p = 0.12; †trend: p = 0.32. Cases and controls in each group were adjusted for age. CI = confidence interval.
Table 3. Association between present body mass index (BMI) and breast cancer risk
BMI
Postmenopausal* Premenopausal†
Cases, n (%) Controls, n (%) Odds ratio (95% CI) Cases, n (%) Controls, n (%) Odds ratio (95% CI)
< 19 6 (5.3) 7 (10.1) 17 (21.3) 59 (21.6)
19–23 37 (32.5) 26 (37.7)1 2.03 (0.65–6.32), p = 0.220 24 (30.0) 142 (52.0)1 1.02 (0.56–1.88), p = 0.945
23–27 45 (39.5) 24 (34.8)1 1.51 (0.83–2.77), p = 0.181 31 (38.8) 58 (21.2) 2.26 (0.59–4.44), p = 0.061
27–31 20 (17.5) 9 (13.0) 1.47 (0.66–3.00), p = 0.383 5 (6.3) 14 (5.1)1 2.06 (0.83–5.09), p = 0.119
> 31 6 (5.3) 3 (4.3)1 1.22 (0.30–5.05), p =0.782, 3 (3.8) 3 (4.3)
Missing 01111, 011111, 0(((((( 0((((((
*Trend: p = 0.06; †trend: p = 0.20. Cases and controls in each group were adjusted for age. CI = confidence interval.
Table 5. Results in different studies when a body mass index
(BMI) of 27 was used as the cut-off point in postmenopausal
women
Study Odds ratio (95% CI) p for trend*
Present study 2.06 (1.08–3.93) < 0.001
Xiao et al, 200113 2.00 (1.20–3.20) 0.003
Taioli et al, 199516 1.50 (1.00–2.30)
van den Brandt ,1.43 (1.21–1.67)‡ 0.001
   et al,† 200022
*p for trend represents the dose-response relationship between BMI
and breast cancer risk; †meta-analysis of 7 cohort studies, including
337,819 women and 4,385 breast cancer cases; ‡relative risk in-
stead of odds ratio. All odds ratios and relative risk were calculated
using BMI at diagnosis. CI = confidence interval.
Table 6. Results in different studies when a body mass index
(BMI) of 27 was used as the cut-off point in premenopausal
women
Study Odds ratio (95% CI) p for trend
Present study 1.32 (0.39–1.43) 0.382
Xiao et al, 200113 1.10 (0.7–1.7)00 0.340
Taioli et al, 199516 0.40 (0.20–0.60)
van den Brandt ,0.97 (0.66–1.44)† 0.007‡
   et al,* 200022
*Meta-analysis of 7 cohort studies, including 337,819 women and
4,385 breast cancer cases; †relative risk instead of odds ratio; ‡the
higher the BMI, the smaller the risk of formation of breast cancer.
All odds ratios and relative risk were calculated using BMI at
diagnosis. CI = confidence interval.
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The association between BMI and risk of breast cancer in
premenopausal women is still unclear, and this controversial
issue should be subjected to further investigation.
Some questions about the use of BMI have been raised.
Some researchers suggest that BMI is simply a reflection of
high fat intake and, therefore, BMI is a surrogate measure.
BMI is certainly associated with an increased risk of breast
cancer in postmenopausal women. The association between
high fat intake and risk of breast cancer is unclear in epidemio-
logical studies.23–28 Some authors suggest that this may be
because high fat intake is very difficult to quantify in such
studies and claim that the best indicator for high fat intake is
BMI. However, because of the controversy around this ques-
tion, it must be answered by a separate and specific study.
Our study has a number of strengths. All subjects in this
case control study were Chinese women from Hong Kong and
all were born and raised in Hong Kong or nearby cities in
China. Present weight and height were measured in the clinic
by medical students after interview, using the same protocol
and instruments in order to minimize potential recall bias.
Lastly, the prevalence of obesity in the study population was
low compared with that in Western countries, allowing an
assessment of association of BMI with breast cancer risk in a
weight range closer to an ideal normal, according to the
standards in Western populations.
Our study, however, may suffer from the inherent limita-
tions of the case control design. In addition, recall inaccuracy
in parameters measuring BMI 5 years before diagnosis may
contribute to the insignificant result. However, we believe the
effect of recall inaccuracy was not significant in the parameters
measuring BMI at diagnosis as all cases were diagnosed in
recent years (1995–2002).
We believe that the recalled data on weight and height are
reliable because most studies find that in both young and
elderly women, ability to recall weight is excellent. The corre-
lation between memory and actual weight 1 year ago, 5 years
ago, 10 years ago and even at the time of menarche are very
good, with correlation coefficients around 0.80–0.99.29–36 These
studies clearly showed that recall data on weight can be used in
epidemiological analysis and have been quoted widely in many
other studies.37–48 In our study, BMI at diagnosis was obtained
by recall of an event 3–5 years earlier. This generally contrib-
utes to a certain amount of inaccuracy. However, people have
better memory for specific events, such as diagnosis of breast
cancer, and this inaccuracy is therefore minimal for these
events.19,49,50 The inaccuracy of memory recall of data at that
moment is therefore minimized.
Survivor bias is another potential pitfall in our study since
the cases we selected were follow-up cases rather than newly
diagnosed cases. However, we believe that the effect of survivor
bias is minimal in our study because many previous studies
showed no relationship between BMI and prognosis of breast
cancer.51–53
In summary, our study found that high BMI at diagnosis
was positively correlated with increased risk of breast cancer in
postmenopausal Chinese women in Hong Kong. A significant
dose-response relationship between BMI at diagnosis and
breast cancer was also demonstrated. This indicates that weight
control may be an effective measure for breast cancer preven-
tion in postmenopausal women. The results also enhance our
understanding of the pathogenesis of breast cancer in post-
menopausal women and emphasize the need for research to
clearly define the underlying mechanisms.
The incidence of breast cancer is rising in Hong Kong.54
The reason is not well understood but we think that it may be
related to better nutrition and increased weight (in terms of
BMI) in the female population in Hong Kong.17 This postula-
tion is preliminary and needs further study.
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